Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer’s Disease Patients
Journal of Alzheimer's Disease · 2024
DOI: 10.3233/jad-240308 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von José Viña und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Freshage Research Group, Faculty of Medicine, University of Valencia, Centro de Investigación Biomédica en Red Fragilidad y…. Hauptthemen laut MEDLINE: Alzheimer Disease, Genistein, Phytoestrogens, Prodromal Symptoms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease is recognized as a complex condition influenced by multiple factors, necessitating a similarly multifaceted approach to treatment. Ideally, interventions should prioritize averting the progression to dementia. Given the chronic nature of the disease, long-term management strategies are required. Within this framework, lifestyle modifications and dietary supplements emerge as appealing options due to their minimal toxicity, limited side effects, and cost-effectiveness. This study presents findings from a double-blind, placebo-controlled bicentric pilot clinical trial, demonstrating the significant cognitive preservation associated with genistein, a phytoestrogen found in soy and various other dietary sources, among individuals with prodromal Alzheimer’s disease. Our prior investigation utilizing APP/PS1 mice elucidated the specific mechanisms through which genistein operates, including anti-amyloid-β, antioxidant, anti-inflammatory, and antiapoptotic effects. These findings underscore the potential of identifying bioactive compounds from dietary sources for the management of Alzheimer’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Freshage Research Group, Faculty of Medicine, University of Valencia, Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable-Instituto de Salud Carlos III (CIBERFES-ISCI…
Zitieren
APA
Viña, J., Borrás, C., & Mas-Bargues, C. (2024). Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer’s Disease Patients. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-240308
Vancouver
Viña J, Borrás C, Mas-Bargues C. Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer’s Disease Patients. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-240308
BibTeX
@article{Via2024,
author = {Viña, José and Borrás, Consuelo and Mas-Bargues, Cristina},
title = {Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer’s Disease Patients},
journal = {Journal of Alzheimer's Disease},
year = {2024},
doi = {10.3233/jad-240308}
}
EUVIMED